Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > More daily? news
View:
Post by Pandora on Feb 10, 2021 6:21pm

More daily? news

 

We're hitting the news boards most days but not with the news everyone is looking for (imho).


Ventripoint issues 131,430 shares for interest payment

 

2021-02-10 16:08 ET - News Release

 

An anonymous director reports

VENTRIPOINT DIAGNOSTICS ISSUES SHARES IN FINAL PAYMENT OF DEBENTURE INTEREST

Ventripoint Diagnostics Ltd. issued an aggregate of 131,430 shares for the final interest payment of $23,274 on convertible debentures issued by the company on Feb. 6, 2020, replacement convertible debentures issued the same date and a convertible debenture issued Sept. 11, 2020. All debentures have been converted to common shares of the company, and interest is calculated to the date of conversion. The shares will be issued at a deemed price based on the closing market price of the shares on the date of conversion, subject to the approval of the TSX Venture Exchange. Two directors of the company will receive a total of 49,255 common shares in final payment of $5,967.20 of interest on their debentures.

Comment by Yajne on Feb 11, 2021 12:11am
looks like some final bits of the balance sheet clean-up, so no worries IMO. Good to go now!